Abstract
Background:
Endocrine organs are highly susceptible to effects of high-dose chemotherapy. The objective of the study was to evaluate endocrine and metabolic complications after hematopoietic stem cell transplantation (HSCT) in children.
Methods:
The patients who underwent HSCT in our center from April 2010 to October 2014 with at least 1 year follow-up were analyzed retrospectively.
Results:
One-hundred children (M/F:59/41; mean age 8.9±4.8 years, mean follow-up time 3.4±1.2 years) were included in the study. Female hypogonadism was the most common endocrine dysfunction (35.7%), followed by growth impairment (29.4%), malnutrition (27.4%), dyslipidemia (26%), low bone mineral density (BMD) (25%), hypothyroidism (13%) and insulin resistance (12%). Patients who underwent HSCT >10 years of age were significantly at risk for hypogonadism, metabolic syndrome, growth impairment and malnutrition (p<0.05).
Conclusions:
Endocrine or metabolic dysfunctions are more prevalent in children who are older than 10 years of age at HSCT. Children who underwent HSCT should be followed-up by a multidisciplinary team during puberty and adolescence.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Bresters D, van Gils IC, Kollen WJ, Ball LM, Oostdijk W, et al. High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study. Bone Marrow Transplant 2010;45:79–85.10.1038/bmt.2009.92Search in Google Scholar PubMed
2. Shi-Xia X, Xian-Hua T, Hai-Qin X, Bo F, Xiang-Feng T. Total body irradiation plus cyclophosphamide versus busulphan with cyclophosphamide as conditioning regimen for patients with leukemia undergoing allogeneic stem cell transplantation: a meta-analysis. Leuk Lymphoma 2010;51:50–60.10.3109/10428190903419130Search in Google Scholar PubMed
3. Chow EJ, Pihoker C, Hunt K, Wilkinson K, Friedman DL. Obesity and hypertension among children after treatment for acute lymphoblastic leukemia. Cancer 2007;110:2313–20.10.1002/cncr.23050Search in Google Scholar PubMed
4. Dvorak CC, Gracia CR, Sanders JE, Cheng EY, Baker KS, et al. NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, and reproductive risks. Biol Blood Marrow Transplant 2011;17:1725–38.10.1016/j.bbmt.2011.10.006Search in Google Scholar PubMed PubMed Central
5. Paris C, Yates L, Lama P, Zepeda AJ, Gutiérrez D, et al. Evaluation of metabolic syndrome after hematopoietic stem cell transplantation in children and adolescents. Pediatr Blood Cancer 2012:59:306–10.10.1002/pbc.24104Search in Google Scholar PubMed
6. WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards based on length/height, weight and age. Acta Pediatrica 2006;95:76–85.10.1111/j.1651-2227.2006.tb02378.xSearch in Google Scholar PubMed
7. National Center for Health Statistics. CDC Growth Charts. Selected percentiles and LMS parameters. Hyattsville, MD: National Center for Health Statistics, 2000.Search in Google Scholar
8. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555–76.10.1542/peds.114.S2.555Search in Google Scholar
9. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976;51:170–9.10.1136/adc.51.3.170Search in Google Scholar PubMed PubMed Central
10. Lem AJ, de Rijke YB, van Toor H, de Ridder MA, Visser TJ, et al. Serum thyroid hormone levels in healthy children from birth to adulthood and in short children born small for gestational age. J Clin Endocrinol Metab 2012;97:3170–8.10.1210/jc.2012-1759Search in Google Scholar PubMed
11. American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care 2015;38:S8–S16.10.2337/dc15-S005Search in Google Scholar PubMed
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.10.1007/BF00280883Search in Google Scholar PubMed
13. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med 2003;157:821–7.10.1001/archpedi.157.8.821Search in Google Scholar PubMed
14. Mayer EI, Dopfer RE, Klingebiel T, Scheel-Walter H, Ranke MB, et al. Longitudinal gonadal function after bone marrow transplantation for acute leymphoblastic leukemia during childhood. Pediatr Transplant 1999;3:38–44.10.1034/j.1399-3046.1999.00006.xSearch in Google Scholar PubMed
15. Goksen D, Darcan S, Coker M, Kose T. Bone mineral density of healthy Turkish children and adolescents. J Clin Densitom 2006;9:84–90.10.1016/j.jocd.2005.08.001Search in Google Scholar PubMed
16. Gordon CM, Leonard MB, Zemel BS. International Society for Clinical Densitometry. 2013 Pediatric Position Development Conference: executive summary and reflections. J Clin Densitom 2014;17:219–24.10.1016/j.jocd.2014.01.007Search in Google Scholar PubMed
17. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M. Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008;122:398–417.10.1542/peds.2007-1894Search in Google Scholar PubMed
18. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, et al. Childhood Cancer Survivor Study. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006;355:1572–82.10.1056/NEJMsa060185Search in Google Scholar PubMed
19. Siklar Z, Berberoglu M. Pediatric hormonal disturbances after hematopoietic stem cell transplantation. Expert Rev Endocrinol Metab 2013;8:81–90.10.1586/eem.12.71Search in Google Scholar PubMed
20. Bailey H, Kappy M, Giller R, Gralla J. Time-course and risk factors of hypothyroidism following allogeneic hematopoietic stem cell transplantation (HSCT) in children conditioned with fractionated total body irradiation. Pediatr Blood Cancer 2008;51:405–9.10.1002/pbc.21634Search in Google Scholar PubMed
21. Dvorak C, Wright N, Wong W, Kristovich K, Matthews E, et al. Safety of hematopoietic stem cell transplantation in children less than three years of age. Pediatr Hematol Oncol 2008;25:705–22.10.1080/08880010802243524Search in Google Scholar PubMed
22. Socie G, Salooja N, Cohen A, Rovelli A, Carreras E, et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood 2003;101:3373–78.10.1182/blood-2002-07-2231Search in Google Scholar
23. Boulad F, Bromley M, Black P, Heller G, Sarafoglou K, et al. Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation. Bone Marrow Transplant 1995; 15:71–6.Search in Google Scholar
24. Jung MH, Cho KS, Lee JW, Chung NG, Cho B, et al. Endocrine complications after hematopoietic stem cell transplantation during childhood and adolescence. J Korean Med Sci 2009;24:1071–77.10.3346/jkms.2009.24.6.1071Search in Google Scholar
25. Kagoya Y, Seo S, Nannya Y, Kurokawa M. Hyperlipidemia after allogeneic stem cell transplantation: prevalence, risk factors, and impact on prognosis. Clin Transplant 2012;26:168–75.10.1111/j.1399-0012.2012.01628.xSearch in Google Scholar
26. Bajwa R, Skeens M, Garee A, Miao Y, Soni S, et al. Metabolic syndrome and endocrine dysfunctions after HSCT in children. Pediatr Transplant 2012;16:872–8.10.1111/petr.12002Search in Google Scholar
27. Baker KS, Chow E, Steinberger J. Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation. Bone Marrow Transplant 2012;47:619–25.10.1038/bmt.2011.118Search in Google Scholar
28. Taskinen M, Saarinen-Pihkala UM, Hovi L, Lipsanen-Nyman M. Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 2000;356:993–7.10.1016/S0140-6736(00)02717-3Search in Google Scholar
29. Traggiai C, Stanhope R, Nussey S, Leiper AD. Diabetes mellitus after bone marrow transplantation during childhood. Med Pediatr Oncol 2003;40:128–9.10.1002/mpo.10098Search in Google Scholar PubMed
30. Chow EJ, Simmons JH, Roth CL, Baker KS, Hoffmeister PA, et al. Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation. Biol Bone Marrow Transplant 2010;16:1674–81.10.1016/j.bbmt.2010.05.016Search in Google Scholar PubMed PubMed Central
31. Sanders JE, Guthrie KA, Hoffmeister PA, Woolfrey AE, Carpenter PA, et al. Final adult height of patients who received hematopoietic cell transplantation in childhood. Blood 2005;105:1348–54.10.1182/blood-2004-07-2528Search in Google Scholar PubMed
32. Mostoufi-Moab S, Ginsberg JP, Bunin N, Zemel BS, Shults J, et al. Body composition abnormalities in long-term survivors of pediatric hematopoietic stem cell transplantation. J Pediatr 2012;160:122–8.10.1016/j.jpeds.2011.06.041Search in Google Scholar PubMed PubMed Central
33. Ruble K, Hayat M, Stewart KJ, Chen A. Body composition after bone marrow transplantation in childhood. Oncol Nurs Forum 2012;39:186–92.10.1188/12.ONF.186-192Search in Google Scholar PubMed PubMed Central
34. Vatanen A, Wilhelmsson M, Borgström B, Gustafsson B, Taskinen M, et al. Ovarian function after allogeneic hematopoietic stem cell transplantation in childhood and adolescence. Eur J Endocrinol 2013;170:211–8.10.1530/EJE-13-0694Search in Google Scholar PubMed
35. Petryk A, Bergemann TL, Polga KM, Ulrich KJ, Raatz SK, et al. Prospective study of changes in bone mineral density and turnover in children after hematopoietic cell transplantation. J Clin Endocrinol Metab 2006;91:899–905.10.1210/jc.2005-1927Search in Google Scholar PubMed
36. Campos DJ, Boguszewski CL, Funke VA, Bonfim CM, Kulak CA, et al. Bone mineral density, vitamin D, and nutritional status of children submitted to hematopoietic stem cell transplantation. Nutrition 2014;30:654–9.10.1016/j.nut.2013.10.014Search in Google Scholar PubMed
37. Pandit A, Garg MK, Kotwal N, Brar KS, Gundgurthi A, et al. Changes in bone mineral density and bone turnover markers in patients undergoing hematopoietic stem cell transplant. Indian J Endocrinol Metab 2015;19:393–8.10.4103/2230-8210.152785Search in Google Scholar PubMed PubMed Central
38. Theintz G, Buchs B, Rizzoli R, Slosman D, Clavien H, et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 1992;75: 1060–5.Search in Google Scholar
39. Turner RT, Riggs BL, Spelsberg TC. Skeletal effects of estrogen. Endocr Rev 1994;15:275–300.Search in Google Scholar
40. Baek KH, Lee WY, Oh KW, Kim HS, Han JH, et al. Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: impact on bone and mineral metabolism. J Clin Endocrinol Metab 2004;89:1246–54.10.1210/jc.2003-031206Search in Google Scholar PubMed
41. Choi YJ, Park SY, Cho WK, Lee JW, Cho KS, et al. Factors related to decreased bone mineral density in childhood cancer survivors. J Korean Med Sci 2013;28:1632–8.10.3346/jkms.2013.28.11.1632Search in Google Scholar PubMed PubMed Central
42. De Laet C, Kanis JA, Odén A, Johanson H, Johnell O, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 2005;16:1330–8.10.1007/s00198-005-1863-ySearch in Google Scholar PubMed
43. Yao S, McCarthy PL, Dunford LM, Roy DM, Brown K, et al. High prevalence of early-onset osteopenia/osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy. Bone Marrow Transplant 2008;41:393–8.10.1038/sj.bmt.1705918Search in Google Scholar PubMed
44. Simmons J, Sheedy C, Lee H, Koh S, Alvarez J, et al. Prevalence of 25-hydroxyvitamin D deficiency in child and adolescent patients undergoing hematopoietic cell transplantation compared to a healthy population. Pediatr Blood Cancer 2013;60:2025–30.10.1002/pbc.24684Search in Google Scholar PubMed
©2017 Walter de Gruyter GmbH, Berlin/Boston
